Breaking News
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. Upgrade now
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details

REFILE-GLOBAL MARKETS-Global stocks rise on recovery hopes

Stock MarketsJan 25, 2021 11:48
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

(Amends lede, corrects 'records' in lede to 'record')
* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn
* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Ritvik Carvalho
LONDON, Jan 25 (Reuters) - Global shares rose to levels just
shy of record highs on Monday, as optimism over a $1.9 trillion
U.S. stimulus plan outweighed rising COVID-19 cases and delays
in vaccine supplies.
European stock markets opened higher, with the pan-European
STOXX 600 .STOXX up 0.3%. The continent's 50 biggest stocks
were also up 0.3% .STOXX50 . .EU
Germany's DAX rose 0.2% .GDAXI , Italy's FTSE MIB index
jumped 0.6% and Britain's FTSE 100 .FTSE rose 0.1%. Spain's
IBEX .IBEX and France's CAC 40 .FCHI faltered, down 0.1%
each.
A rally in U.S. tech stocks to near record highs on Friday
helped fuel gains in their counterparts in Asia and Europe. A
European basket of tech stocks gained 1.2% .SX8P . In Asia,
Chinese tech giant Tencent soared 11% 0700.HK .
MSCI's All Country World index, which tracks stocks across
49 countries, was up 0.3% on the day. .MIWD00000PUS
Global equity markets have scaled record highs in recent
days on bets COVID-19 vaccines will start to reduce infection
rates worldwide and on a stronger U.S. economic recovery under
President Joe Biden.
Investors are also wary about towering valuations amid
questions over the efficiency of the vaccines in curbing the
pandemic and as U.S. lawmakers continue to debate a coronavirus
aid package. All eyes are on Washington D.C. as U.S. lawmakers agreed
that getting the COVID-19 vaccine to Americans should be a
priority even as they lock horns over the size of the U.S.
pandemic relief package. Financial markets have been eyeing a massive package, though
disagreements have meant months of indecision in a country
suffering more than 175,000 COVID-19 cases a day with millions
out of work.
Global COVID-19 cases are inching towards 100 million with
more than 2 million dead. Despite the recent outperformance in tech stocks, investors
have reiterated views that cyclical and value stocks will
outperform as economies recover.
"While renewed lockdowns and mobility restrictions around
the world have supported 2020 stay-home beneficiaries, we do not
think the rotation into cyclicals is over," said Mark Haefele,
chief investment officer at UBS Global Wealth Management.
Haefele said a broadening economic recovery, a normalization
of economic activity as vaccination programmes continue, and
attractive valuations for emerging-market stocks relative to
developed markets were reasons for UBS shifting its preference
to emerging markets.
On Friday, the Dow .DJI fell 0.57%, the S&P 500 .SPX
lost 0.30% and the Nasdaq .IXIC added 0.09%. The three main
U.S. indexes closed higher for the week, with the Nasdaq rising
over 4%.
"Small/Mid (SMID) cap earnings were more impacted by the
pandemic, and we project an earnings rebound more than 2x larger
than the S&P 500," said BoFA strategists in a note.
"Historically, when Democrats control both the White House
and Congress, SMID-cap returns have exceeded large cap. Also,
SMID-caps are more domestically-oriented, which should benefit
from on-shoring and infrastructure spending."
Sentiment in Asia was boosted by a report that China had
surpassed the United States to be the largest recipient of
foreign direct investment in 2020 with $163 billion in inflows.
MSCI's broadest index of Asia-Pacific shares outside Japan
.MIAPJ0000PUS rose to 726.46, close to last week's record high
of 727.31.
The benchmark is up nearly 9% so far in January, on track
for its fourth straight monthly rise.
Japan's Nikkei .N225 rebounded from falls in early trading
to be up 0.7%.
Australian shares .AXJO added 0.4% after the country's
drug regulator approved the Pfizer/BioNTech COVID-19 vaccine
with a phased rollout likely late next month. Chinese shares rose, with the blue-chip CSI300 index
.CSI300 up 1.1%. Hong Kong's Hang Seng index .HSI leapt
nearly 2% led by technology stocks.
Rebounding sentiment in markets put further pressure on the
dollar, =USD which eased 0.1% to 90.163 against a basket of
currencies. Elsewhere in currencies, major pairs were trapped in
a tight range as markets awaited the Federal Reserve's Wednesday
meeting.
The euro EUR= was flat at $1.2167, while sterling GBP=
was last up at $1.3697. FRX/ The Japanese yen JPY= was flat
at 103.76 per dollar.
In commodities, Brent LCOc1 gained 0.65% to $55.77 a
barrel and U.S. crude CLc1 rose 0.75% to $52.66.
Gold fell 0.1% to $1,850 an ounce. XAU=


<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Emerging markets http://tmsnrt.rs/2ihRugV
Global asset performance http://tmsnrt.rs/2yaDPgn
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

REFILE-GLOBAL MARKETS-Global stocks rise on recovery hopes
 

Related Articles

Tokyo's Nikkei share average opens up 1.57 pct
Tokyo's Nikkei share average opens up 1.57 pct By Reuters - Mar 01, 2021

TOKYO, March 1 (Reuters) - Japan's benchmark Nikkei average .N225 opened up 1.57 percent at 29,419.45 on Monday, while the broader Topix .TOPX gained 1.29 percent at 1,888.61.

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email